| Mr Peter J Casano, MD | |
|
1038 River Oaks Dr, Flowood, MS 39232 | |
| (601) 932-5244 | |
| (601) 939-0545 |
| Full Name | Mr Peter J Casano |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 36 Years |
| Location | 1038 River Oaks Dr, Flowood, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134239171 | NPI | - | NPPES |
| 00126164 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0905X | Otolaryngology - Otolaryngology/facial Plastic Surgery | 12096 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ochsner Medical Center-hancock | Bay saint louis, MS | Hospital |
| Ochsner Clinic Foundation | New orleans, LA | Hospital |
| Slidell Memorial Hospital | Slidell, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ochsner Mississippi, Llc | 0143580993 | 113 |
News Archive
Type 2 diabetes is a major contributor to mortality in patients with bipolar disorder who are admitted to general hospitals, a study shows.
Albert Einstein College of Medicine of Yeshiva University has launched SuperAgers.com, a new website that features the latest information on more than a decade of aging research at Einstein.
BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announces that the data from its completed Phase I/II clinical study of OncoVEXGM-CSF for the first line treatment of head and neck cancer is being published today in Clinical Cancer Research, an ASCO publication.
Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three and six-month periods ended June 30, 2010. Net service revenue increased 11.8% while net income attributable to Amedisys, Inc., decreased 8.2% over the three-month period ended June 30, 2009.
› Verified 6 days ago
| Entity Name | River Oaks Management Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922029040 PECOS PAC ID: 0345233110 Enrollment ID: O20040407000093 |
News Archive
Type 2 diabetes is a major contributor to mortality in patients with bipolar disorder who are admitted to general hospitals, a study shows.
Albert Einstein College of Medicine of Yeshiva University has launched SuperAgers.com, a new website that features the latest information on more than a decade of aging research at Einstein.
BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announces that the data from its completed Phase I/II clinical study of OncoVEXGM-CSF for the first line treatment of head and neck cancer is being published today in Clinical Cancer Research, an ASCO publication.
Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three and six-month periods ended June 30, 2010. Net service revenue increased 11.8% while net income attributable to Amedisys, Inc., decreased 8.2% over the three-month period ended June 30, 2009.
› Verified 6 days ago
| Entity Name | Flowood River Oaks Hma Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801128798 PECOS PAC ID: 5890825004 Enrollment ID: O20100615000668 |
News Archive
Type 2 diabetes is a major contributor to mortality in patients with bipolar disorder who are admitted to general hospitals, a study shows.
Albert Einstein College of Medicine of Yeshiva University has launched SuperAgers.com, a new website that features the latest information on more than a decade of aging research at Einstein.
BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announces that the data from its completed Phase I/II clinical study of OncoVEXGM-CSF for the first line treatment of head and neck cancer is being published today in Clinical Cancer Research, an ASCO publication.
Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three and six-month periods ended June 30, 2010. Net service revenue increased 11.8% while net income attributable to Amedisys, Inc., decreased 8.2% over the three-month period ended June 30, 2009.
› Verified 6 days ago
| Entity Name | Ochsner Mississippi, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538674239 PECOS PAC ID: 0143580993 Enrollment ID: O20180216000366 |
News Archive
Type 2 diabetes is a major contributor to mortality in patients with bipolar disorder who are admitted to general hospitals, a study shows.
Albert Einstein College of Medicine of Yeshiva University has launched SuperAgers.com, a new website that features the latest information on more than a decade of aging research at Einstein.
BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announces that the data from its completed Phase I/II clinical study of OncoVEXGM-CSF for the first line treatment of head and neck cancer is being published today in Clinical Cancer Research, an ASCO publication.
Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three and six-month periods ended June 30, 2010. Net service revenue increased 11.8% while net income attributable to Amedisys, Inc., decreased 8.2% over the three-month period ended June 30, 2009.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Peter J Casano, MD 2550 Flowood Dr, 402, Flowood, MS 39232-9303 Ph: (601) 932-5244 | Mr Peter J Casano, MD 1038 River Oaks Dr, Flowood, MS 39232 Ph: (601) 932-5244 |
News Archive
Type 2 diabetes is a major contributor to mortality in patients with bipolar disorder who are admitted to general hospitals, a study shows.
Albert Einstein College of Medicine of Yeshiva University has launched SuperAgers.com, a new website that features the latest information on more than a decade of aging research at Einstein.
BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announces that the data from its completed Phase I/II clinical study of OncoVEXGM-CSF for the first line treatment of head and neck cancer is being published today in Clinical Cancer Research, an ASCO publication.
Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three and six-month periods ended June 30, 2010. Net service revenue increased 11.8% while net income attributable to Amedisys, Inc., decreased 8.2% over the three-month period ended June 30, 2009.
› Verified 6 days ago
Dr. John P Hines, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2550 Flowood Dr Ste 303, Flowood, MS 39232 Phone: 601-709-7700 Fax: 601-709-7701 | |
Beverly Claire Fulcher, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2550 Flowood Dr Ste 303, Flowood, MS 39232 Phone: 601-709-7700 Fax: 601-944-5551 | |
Stephen Frederick Lee, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2550 Flowood Drive, Suite 303, Flowood, MS 39232 Phone: 601-709-7700 Fax: 601-709-7701 | |
Laura House Christopher, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 290 E Layfair Dr, Flowood, MS 39232 Phone: 601-981-2825 | |
Dr. Charles Ron Cannon, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1038 River Oaks Dr, Flowood, MS 39232 Phone: 601-932-5244 Fax: 601-939-0545 | |
Clarence Michael Osborne, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2550 Flowood Drive, Suite 303, Flowood, MS 39232 Phone: 601-709-7700 Fax: 601-709-7701 |